Sweden Pauses AstraZeneca Covid Shot While EMA Reviews

March 16, 2021, 8:19 AM UTC

Sweden has decided to pause Covid-19 vaccinations using AstraZeneca Plc’s shot, the country’s health agency said in a statement.

The agency will await the outcome of reviews conducted by the European Medicines Agency and the Swedish health department on possible side effects from the vaccine.

The Nordic nation joins a growing number of European countries, including Germany, France and Italy, that have this week decided to suspend the use of the vaccine.

Read More: Europe Vaccine Campaign in Turmoil Ahead of Astra Verdict

To contact the reporter on this story:
Anton Wilen in Stockholm at awilen@bloomberg.net

To contact the ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.